If you wonder where the Federal Government’s $787 billion stimulus package is being spent, you’ll be pleased to hear that a $ 7.5 million grant has been designated for infertility research at the Yale School of Public Health. It was awarded through the National Institutes of Health (NIH).
Professor Heping Zhang’s Data Coordination Center team, which is part of the National Institute of Child Health and Human Development’s Reproductive Medicine Network, will focus on the drug Letrozole with a view to producing an increase in single births, which result in safer pregnancies.
The majority of fertility treatments currently available result in multiple pregnancies which boost the risk of premature births and birth defects. Nine-hundred infertile women will be recruited at seven sites throughout the U.S. for the two-year trial which will be followed by data analysis by the research team.
Two common fertility drugs, Clomid and gonadotrophins will also be used in the study.
To read more: